E09.331
Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E09.331 refers to a specific type of diabetes mellitus caused by drugs or chemicals, which is accompanied by moderate nonproliferative diabetic retinopathy with macular edema. This condition involves both systemic blood sugar management issues and eye-related problems that can impact vision. Recognizing the link between medication exposure and diabetic complications is essential for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Use of certain medications such as glucocorticoids, thiazide diuretics, or some antipsychotics Exposure to chemicals that interfere with insulin production or effectiveness Pre-existing risk factors for diabetes, such as obesity or genetic predisposition, combined with drug/chemical effects
Key Symptoms: Blurred or distorted vision Swelling or edema in the macula, leading to visual impairment Areas of vision loss or dark spots in vision Increased blood sugar levels leading to typical diabetes symptoms like frequent urination, increased thirst, and fatigue Possible eye redness or discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history review, blood tests to assess blood glucose levels, and eye examinations including retinal imaging. The presence of moderate nonproliferative diabetic retinopathy with associated macular edema is confirmed through detailed eye imaging such as optical coherence tomography (OCT). Additionally, a review of recent medication use helps identify drug-induced causes.
Treatment Protocols: Treatment strategies focus on managing blood sugar levels and addressing eye complications. Common approaches include: - Adjusting or discontinuing the causative medication under medical supervision - Tight control of blood glucose through diet, exercise, and medications - Eye treatments such as laser therapy or injections to reduce macular edema - Regular eye examinations to monitor progression and response to treatment - Managing blood pressure and cholesterol to prevent further vascular damage Coordination between endocrinologists, ophthalmologists, and primary care providers is vital for comprehensive management.
Clinical Advice & FAQs
Billing Guidance
Is E09.331 a billable ICD-10 code?
Yes, E09.331 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.331?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
